🇺🇸 FDA
Patent

US 10821117

Estrogen therapy for brain gray matter atrophy and associated disability

granted A61KA61K31/565A61K31/566

Quick answer

US patent 10821117 (Estrogen therapy for brain gray matter atrophy and associated disability) held by The Regents of the University of California expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/565, A61K31/566, A61K31/57, A61K49/06